NLS Pharmaceutics Statistics Share Statistics NLS Pharmaceutics has 3.6M
shares outstanding. The number of shares has increased by 206.97%
in one year.
Shares Outstanding 3.6M Shares Change (YoY) 206.97% Shares Change (QoQ) 45.51% Owned by Institutions (%) 22.34% Shares Floating 2.27M Failed to Deliver (FTD) Shares 7,364 FTD / Avg. Volume 2.81%
Short Selling Information The latest short interest is 115.06K, so 2.34% of the outstanding
shares have been sold short.
Short Interest 115.06K Short % of Shares Out 2.34% Short % of Float 2.56% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -73.77 and the forward
PE ratio is 0.06.
NLS Pharmaceutics's PEG ratio is
1.19.
PE Ratio -73.77 Forward PE 0.06 PS Ratio 0 Forward PS 0.1 PB Ratio -101.65 P/FCF Ratio -92.72 PEG Ratio 1.19
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NLS Pharmaceutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.23,
with a Debt / Equity ratio of -0.18.
Current Ratio 0.23 Quick Ratio 0.23 Debt / Equity -0.18 Debt / EBITDA -0.14 Debt / FCF -0.17 Interest Coverage -81.34
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.03M Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -62.48% in the
last 52 weeks. The beta is 0.14, so NLS Pharmaceutics's
price volatility has been higher than the market average.
Beta 0.14 52-Week Price Change -62.48% 50-Day Moving Average 2.29 200-Day Moving Average 2.14 Relative Strength Index (RSI) 60.47 Average Volume (20 Days) 262,332
Income Statement
Revenue n/a Gross Profit -11.41K Operating Income -11.81M Net Income -12.17M EBITDA -11.8M EBIT -11.81M Earnings Per Share (EPS) -0.32
Full Income Statement Balance Sheet The company has 897.68K in cash and 1.63M in
debt, giving a net cash position of -736.07K.
Cash & Cash Equivalents 897.68K Total Debt 1.63M Net Cash -736.07K Retained Earnings -70.37M Total Assets 1.19M Working Capital -6.53M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.68M
and capital expenditures -4, giving a free cash flow of -9.68M.
Operating Cash Flow -9.68M Capital Expenditures -4 Free Cash Flow -9.68M FCF Per Share -0.25
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields NLSP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for NLSP.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 27, 2024. It was a
backward
split with a ratio of 1:40.
Last Split Date Sep 27, 2024 Split Type backward Split Ratio 1:40
Scores Altman Z-Score -148.3 Piotroski F-Score 1
